Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Pepper, M. S.
	Articles by Montesano, R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Pepper, M. S.
	Articles by Montesano, R.

Bhatt, H., Brunet, L. J. and Stewart, C. L (1991). Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc. Nat. Acad. Sci. USA 88, 11408-11412.[Abstract/Free Full Text]

Brown, M. A., Metcalf, D. and Gough, N. M (1994). Leukemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6, 300-309.[Medline]

Conquet, F. and Br\236let, P (1990). Developmental expression of myeloid leukemia inhibitory factor gene in preimplantation blastocysts and in extraembryonic tissue of mouse embryos. Mol. Cell. Biol 10, 3801-3805.[Abstract/Free Full Text]

Conquet, F., Peyrieras, N., Tiret, L. and Br\236let, P (1992). Inhibited gastrulation in mouse embryos overexpressing the leukemia inhibitory factor. Proc. Nat. Acad. Sci. USA 89, 8195-8199.[Abstract/Free Full Text]

Ferrara, N., Leung, D. W., Cachianes, G., Winer, J. and Henzel., W. J (1991). Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Meth. Enzymol 198, 391-404.[Medline]

Ferrara, N., Jakeman, L., Houck, K. and Leung, D. W (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 13, 18-32.[Medline]

Ferrara, N., Winer, J. and Henzel., W. J (1992). Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitory factor. Proc. Nat. Acad. Sci. USA 89, 698-702.[Abstract/Free Full Text]

Fisher, R., Waller, E. K., Grossi, G., Thompson, D., Tizard, R. and Schleuning, W.-D (1985). Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. J. Biol. Chem 260, 11223-11230.[Abstract/Free Full Text]

Flaumenhaft, R., Abe, M., Mignatti, P. and Rifkin, D. B (1992). Basic fibroblast growth factor-induced activation of latent transforming growth factorin endothelial cells: regulation of plasminogen activator activity. J. Cell Biol 118, 901-909.[Abstract/Free Full Text]

Folkman, J. and Klagsbrun, M (1987). Angiogenic factors. Science 235, 442-447.[Abstract/Free Full Text]

Furie, M. B., Cramer, E. B., Naprstek, B. L. and Silverstein, S. C (1984). Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J. Cell Biol 98, 1033-1041.[Abstract/Free Full Text]

Gearing, D. P., Gough, N. M., King, J. A., Hilton, D. J., Nicola, N. A., Simpson, R. J., Nice, E. C., Kelso, A. and Metcalf, D (1987). Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J 6, 3995-4002.[Medline]

Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel, S. D., Thut, C. J., McGourty, J., Brasher, K. K., King, J. A., Gillis, S., Mosley, B., Ziegler, S. F. and Cosman, D (1992). The IL-6 signal transducer, gp130: anoncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434-1437.[Abstract/Free Full Text]

Gillet, N. A., Lowe, D., Lu, L., Chan, C. and Ferrara, N (1993). Leukemia inhibitory factor expression in human carotid plaques: possible mechanism for inhibition of large vessel endothelial regrowth. Growth Factors 9, 301-305.[Medline]

Hilton, D. J., Nicola, N. A., Gough, N. M. and Metcalf, D (1988). Resolution of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemia cell lines. J. Biol. Chem 263, 9238-9243.[Abstract/Free Full Text]

Hilton, D. J. and Gough, N. M (1991). Leukemia inhibitory factor: a biological perspective. J. Cell. Biochem 46, 21-26.[Medline]

Hilton, D. J (1992). LIF: lots of interesting functions. Trends Biochem. Sci 17, 72-76.[Medline]

Ip, N. Y., Nye, S. H., Boulton, T. G., Davis, S., Taga, T., Li, Y., Birren, S. J., Yasukawa, K., Kishimoto, T., Anderson, D. J., Stahl, N. and Yancopoulos, G. D (1992). CNTF and LIF act on neuronal cells via shared signalling pathways that involve the Il-6 signal transducing receptor component gp130. Cell 69, 1121-1132.[Medline]

Klagsbrun, M. and D'Amore, P. A (1991). Regulators of angiogenesis. Annu. Rev. Physiol 53, 217-239.[Medline]

Kr\212tzschmar, J., Haendler, B., Kojima, S., Rifkin, D. B. and Schleuning, W.-D (1993). Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene 125, 177-183.[Medline]

Kurzrock, R., Estrov, Z., Wetzler, M., Gutterman, J. U. and Talpaz, M (1991). LIF: not just a leukemia inhibitory factor. Endocrine Rev 12, 208-217.[Abstract]

Lotz, M., Moats, T. and Villiger, P. M (1992). Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J. Clin. Invest 90, 888-896.

Lubbert, M., Mantovani, L., Lindemann, A., Mertelsmann, R. and Herrmann, F (1991). Expression of leukemia inhibitory factor is regulated in human mesenchymal cells. Leukemia 5, 361-365.[Medline]

Madri J. A., Pratt B. M. and Tucker, A. M (1988). Phenotypic modulation of endothelial cells by transforming growth factor-depends on the composition and organization of the extracellular matrix. J. Cell Biol 106, 1375-1384.[Abstract/Free Full Text]

Merwin, J. R., Anderson, J. M., Kocher, O., van Itallie, C. M. and Madri, J. A (1990). Transforming growth factor beta1modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J. Cell. Physiol 142, 117-128.[Medline]

Metcalf, D. and Gearing, D. P (1989). A myelosclerotic syndrome in mice engrafted with cells producing high levels of leukemia inhibitory factor. Leukemia 3, 847-852.[Medline]

Metcalf, D. and Gearing, D. P (1989). Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc. Nat. Acad. Sci. USA 86, 5948-5952.[Abstract/Free Full Text]

Metcalf, D., Nicola, N. A. and Gearing, D. P (1990). Effects of injected leukemia inhibitory factor on hemopoietic and other tissues in mice. Blood 76, 50-56.[Abstract/Free Full Text]

Metcalf, D (1992). Leukemia inhibitory factor- a puzzling polyfunctional regulator. Growth Factors 7, 169-173.[Medline]

Mignatti P., Tsuboi, R., Robbins E. and Rifkin, D. B (1989). In vitro angiogenesis on the human amniotic membrane: requirements for basic fibroblast growth factor-induced proteases. J. Cell Biol 108, 671-682.[Abstract/Free Full Text]

Montesano, R. and Orci, L (1985). Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42, 469-477.[Medline]

Montesano, R., Vassalli, J.-D., Baird, A., Guillemin, R. and Orci, L (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Nat. Acad. Sci. USA 83, 7297-7301.[Abstract/Free Full Text]

Muller, G., Behrens, J., Nussbaumer, U., B\232hlen, P. and Birchmeier, W (1987). Inhibitory action of transforming growth factoron endothelial cells. Proc. Nat. Acad. Sci. USA 84, 5600-5604.[Abstract/Free Full Text]

Murray, R., Lee, F. and Chiu, C.-P (1990). The genes for leukemia inhibitory factor and interleukin-6 are expressed in mouse blastocysts prior to the onset of hemopoiesis. Mol. Cell. Biol 10, 4953-4956.[Abstract/Free Full Text]

Nathan, C. and Sporn, M (1991). Cytokines in context. J. Cell Biol 113, 981-986.[Free Full Text]

Pepper, M. S., Vassalli, J.-D., Montesano, R. and Orci, L (1987). Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell Biol 105, 2535-2541.[Abstract/Free Full Text]

Pepper, M. S. and Montesano, R (1990). Proteolytic balance and capillary morphogenesis. Cell Diff. Dev 32, 319-328.[Medline]

Pepper, M. S., Belin, D., Montesano, R., Orci, L. and Vassalli, J.-D (1990). Transforming growth factor beta-1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol 111, 743-755.[Abstract/Free Full Text]

Pepper, M. S., Montesano, R., Orci, L. and Vassalli, J.-D (1991). Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta. Biochem. Biophys. Res. Commun 176, 633-638.[Medline]

Pepper, M. S., Montesano, R., Vassalli, J.-D. and Orci, L (1991). Chondrocytes inhibit endothelial sprout formation in vitro: evidence for involvement of a transforming growth factor-beta. J. Cell. Physiol 146, 170-179.[Medline]

Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R (1992). Potent synergism between basic fibroblast growth factor and vascular endothelial growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun 189, 824-831.[Medline]

Pepper, M. S., Montesano, R., El Aoumari, A., Gros, D., Orci, L. and Meda, P (1992). Coupling and connexin43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol 262, 1246-.

Pepper, M. S., Sappino, A.-P., St\232cklin, R., Montesano, R., Orci, L. and Vassalli., J.-D (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol 122, 673-684.[Abstract/Free Full Text]

Pepper, M. S., Vassalli, J.-D., Orci, L. and Montesano, R (1993). : Biphasic effect of transforming growth factor-1 on in vitro angiogenesis. Exp. Cell Res 204, 356-363.[Medline]

Pepper, M. S., Vassalli, J.-D., Wilks, J. W., Schweigerer, L., Orci L. and Montesano, R (1994). Modulation of bovine microvascular endothelial cellproteolytic properties by inhibitors of angiogenesis. J. Cell. Biochem 55, 419-434.[Medline]

Rathjen, P. D., Nichols, J., Toth, S., Edwards, D. R., Heath, J. K. and Smith, A. G (1990). Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes. Dev 4, 2308-2318.[Abstract/Free Full Text]

Shen, M. M. and Leder, P (1992). Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc. Nat. Acad. Sci. USA 89, 8240-8244.[Abstract/Free Full Text]

Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H., Gadi, I., K\232ntgen, F. and Abbondanzo, S. J (1992). Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359, 76-79.[Medline]

Tomida, M., Yamamoto-Yamaguchi, Y. and Hozumi, M (1984). Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J. Biol. Chem 259, 10978-10982.[Abstract/Free Full Text]

Vassalli, J.-D., Hamilton, J. and Reich, E (1976). Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell 8, 271-281.[Medline]

Vassalli, J.-D. and Belin, D (1987). Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214, 187-191.[Medline]

Vassalli, J.-D., Sappino, A.-P. and Belin, D (1991). The plasminogen activator/plasmin system. J. Clin. Invest 88, 1067-1072.

Zetter, B (1988). Angiogenesis. State of the art. Chest 93, 159-.[Abstract/Free Full Text]

This article has been cited by other articles:

A. Ueda, M. Koga, M. Ikeda, S. Kudo, and K. Tanishita
Effect of shear stress on microvessel network formation of endothelial cells with in vitro three-dimensional model
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H994 - H1002.
[Abstract] [Full Text] [PDF]

B. E. Rolfe, S. Stamatiou, C. J. World, L. Brown, A. C. Thomas, J. A. Bingley, N. F. Worth, and J. H. Campbell
Leukaemia inhibitory factor retards the progression of atherosclerosis
Cardiovasc Res, April 1, 2003; 58(1): 222 - 230.
[Abstract] [Full Text] [PDF]

J. R. A. Sherwin, S. K. Smith, A. Wilson, and A. M. Sharkey
Soluble gp130 is Up-Regulated in the Implantation Window and Shows Altered Secretion in Patients with Primary Unexplained Infertility
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3953 - 3960.
[Abstract] [Full Text] [PDF]

J.-C. Tille, J. Wood, S.J. Mandriota, C. Schnell, S. Ferrari, J. Mestan, Z. Zhu, L. Witte, and M. S. Pepper
Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1073 - 1085.
[Abstract] [Full Text] [PDF]

A. Bader, H. Al-Dubai, and G. Weitzer
Leukemia Inhibitory Factor Modulates Cardiogenesis in Embryoid Bodies in Opposite Fashions
Circ. Res., April 14, 2000; 86(7): 787 - 794.
[Abstract] [Full Text] [PDF]

H Paradis and R. Gendron
LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase
J. Cell Sci., January 12, 2000; 113(23): 4331 - 4339.
[Abstract] [PDF]

M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria
Oncostatin M Induces Angiogenesis In Vitro and In Vivo
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1835 - 1842.
[Abstract] [Full Text] [PDF]

P. L. M. Dahia and A. B. Grossman
The Molecular Pathogenesis of Corticotroph Tumors
Endocr. Rev., April 1, 1999; 20(2): 136 - 155.
[Abstract] [Full Text]

A.M. Sharkey, A. King, D.E. Clark, T.D. Burrows, P.P. Jokhi, D.S. Charnock-Jones, Y.W. Loke, and S.K. Smith
Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy
Biol Reprod, February 1, 1999; 60(2): 355 - 364.
[Abstract] [Full Text] [PDF]

G Collo and M. Pepper
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro
J. Cell Sci., January 2, 1999; 112(4): 569 - 578.
[Abstract] [PDF]

H. Lee, I. Struman, C. Clapp, J. Martial, and R. I. Weiner
Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression
Endocrinology, September 1, 1998; 139(9): 3696 - 3703.
[Abstract] [Full Text] [PDF]

S. Mandriota and M. Pepper
Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor
J. Cell Sci., January 9, 1997; 110(18): 2293 - 2302.
[Abstract] [PDF]

E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond
Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
J. Cell Sci., January 4, 1997; 110(7): 871 - 879.
[Abstract] [PDF]

S. J. Mandriota, P.-A. Menoud, and M. S. Pepper
Transforming Growth Factor beta1 Down-regulates Vascular Endothelial Growth Factor Receptor 2/flk-1 Expression in Vascular Endothelial Cells
J. Biol. Chem., May 10, 1996; 271(19): 11500 - 11505.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Pepper, M. S.

Articles by Montesano, R.

Search for Related Content

PubMed

PubMed Citation

Articles by Pepper, M. S.

Articles by Montesano, R.

				B. E. Rolfe, S. Stamatiou, C. J. World, L. Brown, A. C. Thomas, J. A. Bingley, N. F. Worth, and J. H. Campbell Leukaemia inhibitory factor retards the progression of atherosclerosis Cardiovasc Res, April 1, 2003; 58(1): 222 - 230. [Abstract] [Full Text] [PDF]

				J. R. A. Sherwin, S. K. Smith, A. Wilson, and A. M. Sharkey Soluble gp130 is Up-Regulated in the Implantation Window and Shows Altered Secretion in Patients with Primary Unexplained Infertility J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3953 - 3960. [Abstract] [Full Text] [PDF]

				J.-C. Tille, J. Wood, S.J. Mandriota, C. Schnell, S. Ferrari, J. Mestan, Z. Zhu, L. Witte, and M. S. Pepper Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1073 - 1085. [Abstract] [Full Text] [PDF]

				A. Bader, H. Al-Dubai, and G. Weitzer Leukemia Inhibitory Factor Modulates Cardiogenesis in Embryoid Bodies in Opposite Fashions Circ. Res., April 14, 2000; 86(7): 787 - 794. [Abstract] [Full Text] [PDF]

				H Paradis and R. Gendron LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase J. Cell Sci., January 12, 2000; 113(23): 4331 - 4339. [Abstract] [PDF]

				M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria Oncostatin M Induces Angiogenesis In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1835 - 1842. [Abstract] [Full Text] [PDF]

				P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]

				A.M. Sharkey, A. King, D.E. Clark, T.D. Burrows, P.P. Jokhi, D.S. Charnock-Jones, Y.W. Loke, and S.K. Smith Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy Biol Reprod, February 1, 1999; 60(2): 355 - 364. [Abstract] [Full Text] [PDF]

				G Collo and M. Pepper Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro J. Cell Sci., January 2, 1999; 112(4): 569 - 578. [Abstract] [PDF]

				H. Lee, I. Struman, C. Clapp, J. Martial, and R. I. Weiner Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression Endocrinology, September 1, 1998; 139(9): 3696 - 3703. [Abstract] [Full Text] [PDF]

				S. Mandriota and M. Pepper Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor J. Cell Sci., January 9, 1997; 110(18): 2293 - 2302. [Abstract] [PDF]

				E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology J. Cell Sci., January 4, 1997; 110(7): 871 - 879. [Abstract] [PDF]

				S. J. Mandriota, P.-A. Menoud, and M. S. Pepper Transforming Growth Factor beta1 Down-regulates Vascular Endothelial Growth Factor Receptor 2/flk-1 Expression in Vascular Endothelial Cells J. Biol. Chem., May 10, 1996; 271(19): 11500 - 11505. [Abstract] [Full Text] [PDF]